ANTI-CXCR3 ANTIBODIES

The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.

Saved in:
Bibliographic Details
Main Authors MICHELE YOUD, TIMOTHY D. CONNORS, TRACEY LODIE, RUIYIN CHU, ELIZABETH MASTERJOHN, KAREN B. CARTER, JENNIFER TEDSTONE, JASON ROBERT PINCKNEY
Format Patent
LanguageEnglish
Portuguese
Published 29.11.2018
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.
Bibliography:Application Number: PT20130702548T